Novel Cu(II)-catalyzed monoarylation of ammonia shows high efficiency and stability in a recyclable catalyst system.
A novel Cu(II)-based heterogeneous catalyst, SBA-15@bis(Py-2-NHNH2)-Cu(II), was prepared via sequential functionalization of SBA-15 with APTES, cyanuric acid, and 2-hydrazinopyridine, followed by Cu(OAc)2 complexation. The catalyst was thoroughly characterized by FT-IR, solid-state13C NMR, TGA, BET, XPS, and EDAX, confirming successful ligand grafting, Cu(II) coordination, and structural integrity. Under optimized conditions in DMSO, the catalyst efficiently promoted ammonia monoarylation with a wide range of aryl halides. It exhibited negligible activity loss and minimal copper leaching (< 0.2%) in the first run and maintained its performance over five consecutive cycles. Hot filtration experiments further confirmed its heterogeneous nature and sustained stability. Post-catalytic characterization by FT-IR and EDAX verified that the catalyst retained its structure and active metal centers. Overall, these results demonstrate that SBA-15@bis(Py-2-NHNH2)-Cu(II) is a robust, recyclable, and sustainable catalyst, providing an effective alternative to precious metals for C-N bond formation.
No takes yet. Share an insight, caveat, or question.
Ghahramani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: